CorMedix (CRMD) Tops Q3 EPS by 4c
CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on CorMedix (CRMD) click here.